<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-822
Date of Submission: 2025-08-09

This report was submitted by a Pharmacist from Andersen-Everett Medical Center concerning patient ANON-PX-2626. The subject is an adult male with a significant medical history including chronic kidney disease, coronary artery disease, asthma, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Levothyroxine administered via the Topical route at a dosage of 476mg, initiated on 2025-07-26 for Hypothyroidism and discontinued on 2025-08-01; Amoxicillin administered via the Intravenous route at a dosage of 23mg, initiated on 2025-07-26 for Bacterial infection and discontinued on 2025-08-01.

On approximately 2025-08-01, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Maculopapular Rash, Diarrhea. The Maculopapular Rash was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed yeah and advised your. The current patient status regarding this symptom is 'Recovering'. The Diarrhea was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed stop and advised data. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 5 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Particular rock how support happen glass image. Raise her store tax.</data>
report_id: ADR-2025-822
report_date: '2025-08-09'
patient_details:
  patient_id: ANON-PX-2626
  gender: Male
  relevant_history:
  - chronic kidney disease
  - coronary artery disease
  - asthma
  - anxiety
suspected_drugs:
- drug_name: Levothyroxine
  dosage: 476mg
  route_of_administration: Topical
  start_date: '2025-07-26'
  indication_for_use: Hypothyroidism
  end_date: '2025-08-01'
- drug_name: Amoxicillin
  dosage: 23mg
  route_of_administration: Intravenous
  start_date: '2025-07-26'
  indication_for_use: Bacterial infection
  end_date: '2025-08-01'
adverse_reactions:
- symptom_name: Maculopapular Rash
  onset_date: '2025-08-01'
  severity: Moderate
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed yeah and advised your.
- symptom_name: Diarrhea
  onset_date: '2025-08-01'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed stop and advised data.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 5
reporting_facility: Andersen-Everett Medical Center
reporter_type: Pharmacist
notes: Particular rock how support happen glass image. Raise her store tax.
